Alan Nurden: Looking Beyond Bleeding in VWD
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared on LinkedIn about a recent article by Dawn Swan et al, published in RPTH Journal:
”A well thought-out and much-needed assessment of the effects of VWD extending beyond the classical bleeding symptoms.
Could someone now do this for the platelet-based bleeding disorder, Glanzmann thrombasthenia (GT)?
And for GT it would be interesting to go beyond well-studied European and North American populations to include Arab, Pakistani, Indian, Chinese, African and South-American populations where cultural and religious heritage may have a bearing on lifestyle.
A complication of GT is that two genes are involved (ITGA2B and ITGB3) and despite hints from older studies the question of whether ITGB3 defects that lead to both alphaIIbbeta3 and alphavbeta3 deficiencies can influence such parameters as bone density and fertility remain unresolved.”
Title: Von Willebrand disease: more than just a bleeding disorder
Authors: Dawn Swan, Michelle Sholzberg, Bethany Samuelson Bannow, Jecko Thachil
Read the Full Article on RPTH Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 29, 2026, 15:50Sweta Agrawal: Expanding Care for PNH Patients in Nepal
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’